Navigation Links
Alexza's AZ-004 Phase IIa Trial Meets Primary Endpoint in Treating,Schizophrenic Patients With Acute Agitation

Initial Analysis Shows Statistically Significant Changes in Agitation Levels With 10 mg AZ-004

PALO ALTO, Calif., March 26, 2007 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. today announced positive initial results from its Phase IIa clinical trial of AZ-004 (Staccato(R) loxapine) in schizophrenic patients with acute agitation. The 10 mg dose of AZ-004 met the primary endpoint of the clinical trial, which was a statistically-significant reduction in the measure of agitation from baseline to the 2-hour post-dose time point, compared to placebo. Alexza also announced today positive top-line results from its Phase IIb clinical trial of AZ-001 (Staccato prochlorperazine) in patients with migraine headache, where AZ-001 met the primary endpoint of the Phase IIb clinical trial.

"AZ-004 is a product candidate that we believe could fill an important unmet need in the acute treatment of agitation in schizophrenic patients," said Thomas B. King, President and CEO of Alexza. "AZ-004 combines drug delivery speed comparable to that of an intravenous injection, but with the simplicity, convenience and ease of administration of a simple, one-breath inhalation."

"Antipsychotic drugs used to treat acute agitation are typically administered by intramuscular injection, usually in a clinic or in an emergency department," said James V. Cassella, PhD, Senior Vice President, Research and Development of Alexza. "The ability to provide a proven drug mechanism of action, coupled with rapid pharmacokinetics and patient self-administration, makes Staccato loxapine a potentially important new drug candidate for treating agitation in schizophrenic patients."

Clinical Trial Design

The Phase IIa clinical trial was designed as a multi-center, randomized, double-blind, placebo-controlled study of 120 patients in an in-patient clinical setting. In the trial, two doses of AZ-004 (Staccato loxapine in 5 and 10
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Alexza Pharmaceuticals to Present AZ-004 (Staccato Loxapine) Clinical Data at the Annual NCDEU Meeting
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:9/16/2014)... LONDON , Sept. 16, 2014 ... wound closure market, Frost & Sullivan recognises Incisive ... Award for Customer Value Leadership. Incisive Surgical,s uniquely-designed, ... closure technology that eliminates the need for patients ... punctures and staple removal  that may result in ...
(Date:9/16/2014)... Sept. 16, 2014  Synereca Pharmaceutics, Inc. ... orally active drugs that restore or increase ... a $1.4 million convertible debt financing. Accele ... sciences accelerator Accele Biopharma, Inc., led the ... nationally recognized private not-for-profit corporation focused on ...
(Date:9/16/2014)... Sept. 16, 2014  Relmada Therapeutics, Inc., (OTCBB: RLMD), ... of chronic pain, announced today that it has entered ... (MSKCC) in a series of animal studies for levorphanol, ... extended release form of levorphanol.  Gavril Pasternak, MD, PhD, ... Dr. Pasternak said, "Levorphanol is a ...
Breaking Medicine Technology:Frost & Sullivan Commends Incisive Surgical for Delivering Superior Customer Value through its Patient-Centric, Cost-Effective INSORB Absorbable Stapler 2Frost & Sullivan Commends Incisive Surgical for Delivering Superior Customer Value through its Patient-Centric, Cost-Effective INSORB Absorbable Stapler 3Frost & Sullivan Commends Incisive Surgical for Delivering Superior Customer Value through its Patient-Centric, Cost-Effective INSORB Absorbable Stapler 4Frost & Sullivan Commends Incisive Surgical for Delivering Superior Customer Value through its Patient-Centric, Cost-Effective INSORB Absorbable Stapler 5Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners 2Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners 3Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners 4Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 2Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 3
... Study Success in Using Virus Enzyme to Treat Mouse ... Be Used to,Prevent Both Ear Infection and Pneumonia in ... -- Parents might one,day give their children a weekly ... them from getting a severe middle ear,infection, based on ...
... the Drug Improves Memory, SARASOTA, Fla., March 22, ... it has received positive,preliminary results in its major ... application for the treatment of Alzheimer's,disease. The clinical ... first human clinical study conducted by a,Florida-based research ...
Cached Medicine Technology:Viral Enzyme Recruited in Fight Against Ear Infection 2Viral Enzyme Recruited in Fight Against Ear Infection 3Sarasota's Roskamp Institute Announces Positive Safety Data in,Human Clinical Study for Alzheimer's Disease 2
(Date:9/16/2014)... HORAN, a leading advisor in employee ... Carl as Vice President – Retirement Services. , Paul ... retirement planning. In addition, he monitors investments, fees and ... Paul has been a retirement services industry professional for ... as a Senior Investigator at the Department of Labor ...
(Date:9/16/2014)... London, UK (PRWEB) September 16, 2014 ... paediatric clinical trials has risen considerably in line with ... USA, over 350 product labels include novel paediatric information ... safety review. In the European countries, there has been ... medicinal products from the submission of old or new ...
(Date:9/16/2014)... Atlanta, GA (PRWEB) September 16, 2014 ... New York Automobile Dealers Association’s newly elected chairman, Robert ... discusses his association’s plans to further the causes of ... also stories from some of the retail automotive industry’s ... Equifax, who explains why it’s important to take a ...
(Date:9/16/2014)... CITY, CALIF. (PRWEB) September 16, 2014 ... center and customer service solutions, announced today that ... Excellence in Learning Award for the creation of ... independent contractor agents. Brandon Hall Group honors companies ... modalities, processes, systems and tools that have helped ...
(Date:9/16/2014)... NJ (PRWEB) September 16, 2014 ... leading Bariatric Surgeon, Leigh Montes, MD, has joined ... Surgery at Christ Hospital. Our system welcomes Dr. ... a medical and surgical weight loss center, helps ... most advanced bariatric surgery procedures, including Gastric Sleeve, ...
Breaking Medicine News(10 mins):Health News:Paul Carl Joins HORAN's Retirement Plan Consulting Organization 2Health News:Paediatric Drug Development Market Analysed by CBR Pharma Insights in In-demand Report Available at MarketPublishers.com 2Health News:Paediatric Drug Development Market Analysed by CBR Pharma Insights in In-demand Report Available at MarketPublishers.com 3Health News:September Issue of Car Biz Today Magazine Available Online 2Health News:LiveOps Wins Silver At The 2014 Brandon Hall Group Excellence In Learning Awards For Best Use Of Social/Collaborative Learning 2Health News:LiveOps Wins Silver At The 2014 Brandon Hall Group Excellence In Learning Awards For Best Use Of Social/Collaborative Learning 3Health News:LiveOps Wins Silver At The 2014 Brandon Hall Group Excellence In Learning Awards For Best Use Of Social/Collaborative Learning 4Health News:Top Bariatric Surgeon Joins CarePoint Health 2Health News:Top Bariatric Surgeon Joins CarePoint Health 3
... ... Leading Physicians of the World has now made their elite group of physicians accessible online. ... put themselves in the hands of an expert physician for their next visit., , ... New York, NY (PRWEB) March 23, ...
... , President & CEO of Medicaid Health Plans of America (MHPA), the leading trade association solely focused on representing Medicaid health plans, issued the following statement after the House ... ... ... ...
... National Alliance on Mental Illness ( NAMI ) has launched StrengthofUs.org , a new online community where young adults living with mental ... ... , , ... ...
... Lindt Chocolate , the world,s leading producer of premium chocolate, today announces the 2010 Lindt Unsung Heroes of Autism . ... affected by autism in their families, homes and communities.   , ... ... ...
... , March 23 Connectyx Technologies Holdings Group, ...  has appointed Dr. James R. Taylor to its ... healthcare and pharmaceutical field. He has written several publications; in ... elite institutions, such as the University of Florida , ...
... ... , ... ... ATLANTA , March 23 Radiotherapy Centers of Georgia (RCOG), a division of RC Cancer Centers announced today ...
Cached Medicine News:Health News:Findatopdoc.com Uses Cutting Edge Technology in Bringing the Leading Physicians of the World Directly to Your Computer For Consumers to Find a Top Doctor 2Health News:MHPA Statement on Health Reform Legislation 2Health News:NAMI Launches Social Networking Site for Young Adults: Mental Health, Finances, Relationships, Music and More 2Health News:NAMI Launches Social Networking Site for Young Adults: Mental Health, Finances, Relationships, Music and More 3Health News:NAMI Launches Social Networking Site for Young Adults: Mental Health, Finances, Relationships, Music and More 4Health News:NAMI Launches Social Networking Site for Young Adults: Mental Health, Finances, Relationships, Music and More 5Health News:NAMI Launches Social Networking Site for Young Adults: Mental Health, Finances, Relationships, Music and More 6Health News:NAMI Launches Social Networking Site for Young Adults: Mental Health, Finances, Relationships, Music and More 7Health News:Lindt USA Announces 'Lindt Unsung Heroes of Autism' 2Health News:Lindt USA Announces 'Lindt Unsung Heroes of Autism' 3Health News:Lindt USA Announces 'Lindt Unsung Heroes of Autism' 4Health News:Lindt USA Announces 'Lindt Unsung Heroes of Autism' 5Health News:Lindt USA Announces 'Lindt Unsung Heroes of Autism' 6Health News:Connectyx Technologies Holdings Group, Inc. Appoints Dr. James R. Taylor to Its Board of Advisors 2Health News:Connectyx Technologies Holdings Group, Inc. Appoints Dr. James R. Taylor to Its Board of Advisors 3Health News:Connectyx Technologies Holdings Group, Inc. Appoints Dr. James R. Taylor to Its Board of Advisors 4Health News:Connectyx Technologies Holdings Group, Inc. Appoints Dr. James R. Taylor to Its Board of Advisors 5Health News:Prostate Cancer Treatment Database Hits Milestone of 12,500 2Health News:Prostate Cancer Treatment Database Hits Milestone of 12,500 3Health News:Prostate Cancer Treatment Database Hits Milestone of 12,500 4Health News:Prostate Cancer Treatment Database Hits Milestone of 12,500 5
BD Vacutainer® PST™ Tubes contain spray-coated lithium heparin and a gel for plasma separation. They are used for plasma determinations in chemistry....
The Erythrocyte Sedimentation Rate (ESR) can be used as a nonspecific search technique in case of suspicion of inflammatory reactions as well as for judgement of their development. VACUETTE ESR tubes...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Glucose tubes contain an anti-coagulant and a stabiliser. The tubes are ideal for glucose and lactate determinations....
Medicine Products: